- Home
- LBRDA vs QGEN Comparison
LBRDA vs QGEN Comparison
Compare LBRDA & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBRDA
- QGEN
- Stock Information
- Founded
- LBRDA 2014
- QGEN 1986
- Country
- LBRDA United States
- QGEN Netherlands
- Employees
- LBRDA N/A
- QGEN N/A
- Industry
- LBRDA Cable & Other Pay Television Services
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LBRDA Telecommunications
- QGEN Health Care
- Exchange
- LBRDA Nasdaq
- QGEN Nasdaq
- Market Cap
- LBRDA 11.2B
- QGEN 9.1B
- IPO Year
- LBRDA N/A
- QGEN 1996
- Fundamental
- Price
- LBRDA $77.30
- QGEN $40.71
- Analyst Decision
- LBRDA Buy
- QGEN Buy
- Analyst Count
- LBRDA 3
- QGEN 9
- Target Price
- LBRDA $94.00
- QGEN $49.79
- AVG Volume (30 Days)
- LBRDA 157.6K
- QGEN 1.6M
- Earning Date
- LBRDA 05-07-2025
- QGEN 05-07-2025
- Dividend Yield
- LBRDA N/A
- QGEN 3.24%
- EPS Growth
- LBRDA 29.85
- QGEN N/A
- EPS
- LBRDA 6.08
- QGEN 0.38
- Revenue
- LBRDA $1,016,000,000.00
- QGEN $1,978,214,000.00
- Revenue This Year
- LBRDA $5.22
- QGEN $4.74
- Revenue Next Year
- LBRDA $2.34
- QGEN $6.52
- P/E Ratio
- LBRDA $12.87
- QGEN $106.96
- Revenue Growth
- LBRDA 3.57
- QGEN 0.66
- 52 Week Low
- LBRDA $47.17
- QGEN $37.63
- 52 Week High
- LBRDA $100.44
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- LBRDA 45.40
- QGEN 51.47
- Support Level
- LBRDA $74.94
- QGEN $38.97
- Resistance Level
- LBRDA $79.45
- QGEN $43.88
- Average True Range (ATR)
- LBRDA 3.71
- QGEN 1.53
- MACD
- LBRDA -0.47
- QGEN 0.18
- Stochastic Oscillator
- LBRDA 42.65
- QGEN 44.87
About LBRDA Liberty Broadband Corporation
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential and small to medium businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).